<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;v=2.17.9.post6+86293ac&amp;utm_medium=rss&amp;ff=20231119031019&amp;fc=20230708114047
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;v=2.17.9.post6+86293ac&amp;utm_medium=rss&amp;ff=20231119031019&amp;fc=20230708114047" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
<language>en</language>
<lastbuilddate>Sun, 19 Nov 2023 08:10:21 +0000</lastbuilddate>
<pubDate>Sat, 18 Nov 2023 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Sapien S3 transcatheter pulmonary valve replacement: an excellent option but not a panacea</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37978947/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 18:ehad769. doi: 10.1093/eurheartj/ehad769. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37978947/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37978947</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad769>10.1093/eurheartj/ehad769</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37978947</guid>
<pubDate>Sat, 18 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Jamil Aboulhosn</dc:creator>
<dc:date>2023-11-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Sapien S3 transcatheter pulmonary valve replacement: an excellent option but not a panacea</dc:title>
<dc:identifier>pmid:37978947</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad769</dc:identifier>
</item>
<item>
<title>Off-the-shelf use of a novel unibody single-branched stent for open repair of a double chimney graft-induced retrograde type A aortic dissection</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37978904/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 18:ehad755. doi: 10.1093/eurheartj/ehad755. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37978904/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37978904</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad755>10.1093/eurheartj/ehad755</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37978904</guid>
<pubDate>Sat, 18 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Yi Xie</dc:creator>
<dc:creator>Peng Yang</dc:creator>
<dc:creator>Jia Hu</dc:creator>
<dc:date>2023-11-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Off-the-shelf use of a novel unibody single-branched stent for open repair of a double chimney graft-induced retrograde type A aortic dissection</dc:title>
<dc:identifier>pmid:37978904</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad755</dc:identifier>
</item>
<item>
<title>Routine use of extracorporeal life support in cardiogenic shock after acute myocardial infarction: the jury is still out</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37978900/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 18:ehad760. doi: 10.1093/eurheartj/ehad760. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37978900/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37978900</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad760>10.1093/eurheartj/ehad760</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37978900</guid>
<pubDate>Sat, 18 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Daniela Pedicino</dc:creator>
<dc:creator>Rocco Vergallo</dc:creator>
<dc:date>2023-11-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Routine use of extracorporeal life support in cardiogenic shock after acute myocardial infarction: the jury is still out</dc:title>
<dc:identifier>pmid:37978900</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad760</dc:identifier>
</item>
<item>
<title>Revisiting the Kv1.5 knockout model: insights and implications for Takotsubo syndrome research</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37978894/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 18:ehad757. doi: 10.1093/eurheartj/ehad757. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37978894/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37978894</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad757>10.1093/eurheartj/ehad757</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37978894</guid>
<pubDate>Sat, 18 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Feng Dong</dc:creator>
<dc:creator>Hamayak Sisakian</dc:creator>
<dc:creator>Vahagn Ohanyan</dc:creator>
<dc:date>2023-11-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Revisiting the Kv1.5 knockout model: insights and implications for Takotsubo syndrome research</dc:title>
<dc:identifier>pmid:37978894</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad757</dc:identifier>
</item>
<item>
<title>Adapting cardiovascular risk prediction models to different populations: the need for recalibration</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37978887/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 18:ehad748. doi: 10.1093/eurheartj/ehad748. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37978887/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37978887</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad748>10.1093/eurheartj/ehad748</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37978887</guid>
<pubDate>Sat, 18 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Lisa Pennells</dc:creator>
<dc:creator>Stephen Kaptoge</dc:creator>
<dc:creator>Emanuele Di Angelantonio</dc:creator>
<dc:date>2023-11-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Adapting cardiovascular risk prediction models to different populations: the need for recalibration</dc:title>
<dc:identifier>pmid:37978887</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad748</dc:identifier>
</item>
<item>
<title>Does MULTISTARS shed light on the timing of complete revascularization in ST-elevation myocardial infarction?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37978876/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 18:ehad733. doi: 10.1093/eurheartj/ehad733. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37978876/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37978876</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad733>10.1093/eurheartj/ehad733</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37978876</guid>
<pubDate>Sat, 18 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Daniela Pedicino</dc:creator>
<dc:creator>Giovanna Liuzzo</dc:creator>
<dc:date>2023-11-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Does MULTISTARS shed light on the timing of complete revascularization in ST-elevation myocardial infarction?</dc:title>
<dc:identifier>pmid:37978876</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad733</dc:identifier>
</item>
<item>
<title>Takotsubo syndrome or Takotsubo-like contractile dysfunction?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37978875/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 18:ehad745. doi: 10.1093/eurheartj/ehad745. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37978875/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37978875</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad745>10.1093/eurheartj/ehad745</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37978875</guid>
<pubDate>Sat, 18 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Liam S Couch</dc:creator>
<dc:creator>Adrian P Banning</dc:creator>
<dc:date>2023-11-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Takotsubo syndrome or Takotsubo-like contractile dysfunction?</dc:title>
<dc:identifier>pmid:37978875</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad745</dc:identifier>
</item>
<item>
<title>Intracardiac pseudophallus</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37978870/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 18:ehad732. doi: 10.1093/eurheartj/ehad732. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37978870/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37978870</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad732>10.1093/eurheartj/ehad732</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37978870</guid>
<pubDate>Sat, 18 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Francisco B Alexandrino</dc:creator>
<dc:creator>Kevin L Greason</dc:creator>
<dc:creator>Ratnasari Padang</dc:creator>
<dc:date>2023-11-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Intracardiac pseudophallus</dc:title>
<dc:identifier>pmid:37978870</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad732</dc:identifier>
</item>
<item>
<title>Structural basis for human Ca&lt;sub>;v&lt;/sub>;1.2 inhibition by multiple drugs and the neurotoxin calciseptine</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37972591/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>Ca(v)1.2 channels play crucial roles in various neuronal and physiological processes. Here, we present cryo-EM structures of human Ca(v)1.2, both in its apo form and in complex with several drugs, as well as the peptide neurotoxin calciseptine. Most structures, apo or bound to calciseptine, amlodipine, or a combination of amiodarone and sofosbuvir, exhibit a consistent inactivated conformation with a sealed gate, three up voltage-sensing domains (VSDs), and a down VSD(II). Calciseptine sits on...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Nov 8:S0092-8674(23)01106-6. doi: 10.1016/j.cell.2023.10.007. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Ca<sub>v</sub>1.2 channels play crucial roles in various neuronal and physiological processes. Here, we present cryo-EM structures of human Ca<sub>v</sub>1.2, both in its apo form and in complex with several drugs, as well as the peptide neurotoxin calciseptine. Most structures, apo or bound to calciseptine, amlodipine, or a combination of amiodarone and sofosbuvir, exhibit a consistent inactivated conformation with a sealed gate, three up voltage-sensing domains (VSDs), and a down VSD<sub>II</sub>. Calciseptine sits on the shoulder of the pore domain, away from the permeation path. In contrast, when pinaverium bromide, an antispasmodic drug, is inserted into a cavity reminiscent of the IFM-binding site in Na<sub>v</sub> channels, a series of structural changes occur, including upward movement of VSD<sub>II</sub> coupled with dilation of the selectivity filter and its surrounding segments in repeat III. Meanwhile, S4-5<sub>III</sub> merges with S5<sub>III</sub> to become a single helix, resulting in a widened but still non-conductive intracellular gate.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37972591/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37972591</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.10.007>10.1016/j.cell.2023.10.007</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37972591</guid>
<pubDate>Thu, 16 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Shuai Gao</dc:creator>
<dc:creator>Xia Yao</dc:creator>
<dc:creator>Jiaofeng Chen</dc:creator>
<dc:creator>Gaoxingyu Huang</dc:creator>
<dc:creator>Xiao Fan</dc:creator>
<dc:creator>Lingfeng Xue</dc:creator>
<dc:creator>Zhangqiang Li</dc:creator>
<dc:creator>Tong Wu</dc:creator>
<dc:creator>Yupeng Zheng</dc:creator>
<dc:creator>Jian Huang</dc:creator>
<dc:creator>Xueqin Jin</dc:creator>
<dc:creator>Yan Wang</dc:creator>
<dc:creator>Zhifei Wang</dc:creator>
<dc:creator>Yong Yu</dc:creator>
<dc:creator>Lei Liu</dc:creator>
<dc:creator>Xiaojing Pan</dc:creator>
<dc:creator>Chen Song</dc:creator>
<dc:creator>Nieng Yan</dc:creator>
<dc:date>2023-11-16</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Structural basis for human Ca&lt;sub>;v&lt;/sub>;1.2 inhibition by multiple drugs and the neurotoxin calciseptine</dc:title>
<dc:identifier>pmid:37972591</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.10.007</dc:identifier>
</item>
<item>
<title>2023 American Heart Association and American Academy of Pediatrics Focused Update on Neonatal Resuscitation: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37970724/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>This 2023 focused update to the neonatal resuscitation guidelines is based on 4 systematic reviews recently completed under the direction of the International Liaison Committee on Resuscitation Neonatal Life Support Task Force. Systematic reviewers and content experts from this task force performed comprehensive reviews of the scientific literature on umbilical cord management in preterm, late preterm, and term newborn infants, and the optimal devices and interfaces used for administering...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Nov 16. doi: 10.1161/CIR.0000000000001181. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">This 2023 focused update to the neonatal resuscitation guidelines is based on 4 systematic reviews recently completed under the direction of the International Liaison Committee on Resuscitation Neonatal Life Support Task Force. Systematic reviewers and content experts from this task force performed comprehensive reviews of the scientific literature on umbilical cord management in preterm, late preterm, and term newborn infants, and the optimal devices and interfaces used for administering positive-pressure ventilation during resuscitation of newborn infants. These recommendations provide new guidance on the use of intact umbilical cord milking, device selection for administering positive-pressure ventilation, and an additional primary interface for administering positive-pressure ventilation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37970724/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37970724</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001181>10.1161/CIR.0000000000001181</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37970724</guid>
<pubDate>Thu, 16 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Nicole K Yamada</dc:creator>
<dc:creator>Edgardo Szyld</dc:creator>
<dc:creator>Marya L Strand</dc:creator>
<dc:creator>Emer Finan</dc:creator>
<dc:creator>Jessica L Illuzzi</dc:creator>
<dc:creator>Beena D Kamath-Rayne</dc:creator>
<dc:creator>Vishal S Kapadia</dc:creator>
<dc:creator>Susan Niermeyer</dc:creator>
<dc:creator>Georg M Schmölzer</dc:creator>
<dc:creator>Amanda Williams</dc:creator>
<dc:creator>Gary M Weiner</dc:creator>
<dc:creator>Myra H Wyckoff</dc:creator>
<dc:creator>Henry C Lee</dc:creator>
<dc:creator>American Heart Association and American Academy of Pediatrics</dc:creator>
<dc:date>2023-11-16</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>2023 American Heart Association and American Academy of Pediatrics Focused Update on Neonatal Resuscitation: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care</dc:title>
<dc:identifier>pmid:37970724</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001181</dc:identifier>
</item>
<item>
<title>Long-Term Mortality in Patients With Severe Hypercholesterolemia Phenotype From a Racial and Ethnically Diverse US Cohort</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37970713/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: In a large, diverse cohort of US patients with the severe hypercholesterolemia phenotype, we identified several patient characteristics associated with increased 9-year all-cause mortality and observed a decrease in statin use over time, in particular for primary prevention. Our results support efforts geared toward early recognition and consistent treatment for patients with severe hypercholesterolemia.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Nov 16. doi: 10.1161/CIRCULATIONAHA.123.064566. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Tools for mortality prediction in patients with the severe hypercholesterolemia phenotype (low-density lipoprotein cholesterol ≥190 mg/dL) are limited and restricted to specific racial and ethnic cohorts. We sought to evaluate the predictors of long-term mortality in a large racially and ethnically diverse US patient cohort with low-density lipoprotein cholesterol ≥190 mg/dL.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We conducted a retrospective analysis of all patients with a low-density lipoprotein cholesterol ≥190 mg/dL seeking care at Montefiore from 2010 through 2020. Patients &lt;18 years of age or with previous malignancy were excluded. The primary end point was all-cause mortality. Analyses were stratified by age, sex, and race and ethnicity. Patients were stratified by primary and secondary prevention. Cox regression analyses were used to adjust for demographic, clinical, and treatment variables.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 18 740 patients were included (37% non-Hispanic Black, 30% Hispanic, 12% non-Hispanic White, and 2% non-Hispanic Asian patients). The mean age was 53.9 years, and median follow-up was 5.2 years. Both high-density lipoprotein cholesterol and body mass index extremes were associated with higher mortality in univariate analyses. In adjusted models, higher low-density lipoprotein cholesterol and triglyceride levels were associated with an increased 9-year mortality risk (adjusted hazard ratio [HR], 1.08 [95% CI, 1.05-1.11] and 1.04 [95% CI, 1.02-1.06] per 20-mg/dL increase, respectively). Clinical factors associated with higher mortality included male sex (adjusted HR, 1.31 [95% CI, 1.08-1.58]), older age (adjusted HR, 1.19 per 5-year increase [95% CI, 1.15-1.23]), hypertension (adjusted HR, 2.01 [95% CI, 1.57-2.57]), chronic kidney disease (adjusted HR, 1.68 [95% CI, 1.36-2.09]), diabetes (adjusted HR, 1.79 [95% CI, 1.50-2.15]), heart failure (adjusted HR, 1.51 [95% CI, 1.16-1.95]), myocardial infarction (adjusted HR, 1.41 [95% CI, 1.05-1.90]), and body mass index &lt;20 kg/m<sup>2</sup> (adjusted HR, 3.36 [95% CI, 2.29-4.93]). A significant survival benefit was conferred by lipid-lowering therapy (adjusted HR, 0.57 [95% CI, 0.42-0.77]). In the primary prevention group, high-density lipoprotein cholesterol &lt;40 mg/dL was independently associated with higher mortality (adjusted HR, 1.49 [95% CI, 1.06-2.09]). Temporal trend analyses showed a reduction in statin use over time (<i>P</i>&lt;0.001). In the most recent time period (2019-2020), 56% of patients on primary prevention and 85% of those on secondary prevention were on statin therapy.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In a large, diverse cohort of US patients with the severe hypercholesterolemia phenotype, we identified several patient characteristics associated with increased 9-year all-cause mortality and observed a decrease in statin use over time, in particular for primary prevention. Our results support efforts geared toward early recognition and consistent treatment for patients with severe hypercholesterolemia.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37970713/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37970713</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064566>10.1161/CIRCULATIONAHA.123.064566</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37970713</guid>
<pubDate>Thu, 16 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Jeremy Miles</dc:creator>
<dc:creator>Andrea Scotti</dc:creator>
<dc:creator>Francesco Castagna</dc:creator>
<dc:creator>Toshiki Kuno</dc:creator>
<dc:creator>Pier Pasquale Leone</dc:creator>
<dc:creator>Augustin Coisne</dc:creator>
<dc:creator>Sebastian Ludwig</dc:creator>
<dc:creator>Carl J Lavie</dc:creator>
<dc:creator>Parag H Joshi</dc:creator>
<dc:creator>Azeem Latib</dc:creator>
<dc:creator>Mario J Garcia</dc:creator>
<dc:creator>Carlos J Rodriguez</dc:creator>
<dc:creator>Michael D Shapiro</dc:creator>
<dc:creator>Salim S Virani</dc:creator>
<dc:creator>Leandro Slipczuk</dc:creator>
<dc:date>2023-11-16</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Long-Term Mortality in Patients With Severe Hypercholesterolemia Phenotype From a Racial and Ethnically Diverse US Cohort</dc:title>
<dc:identifier>pmid:37970713</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.064566</dc:identifier>
</item>
<item>
<title>Reply: Omega-3 Fatty Acids and Atrial Fibrillation: The Importance of the Clinical Question</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37968027/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 21;82(21):e207. doi: 10.1016/j.jacc.2023.09.808.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37968027/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37968027</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.09.808>10.1016/j.jacc.2023.09.808</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37968027</guid>
<pubDate>Wed, 15 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Frank Qian</dc:creator>
<dc:creator>David Siscovick</dc:creator>
<dc:date>2023-11-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reply: Omega-3 Fatty Acids and Atrial Fibrillation: The Importance of the Clinical Question</dc:title>
<dc:identifier>pmid:37968027</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.09.808</dc:identifier>
</item>
<item>
<title>Omega-3 Fatty Acids and Atrial Fibrillation: The Difference Between Dietary Consumption and Supplementation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37968026/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 21;82(21):e205. doi: 10.1016/j.jacc.2023.08.057.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37968026/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37968026</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.08.057>10.1016/j.jacc.2023.08.057</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37968026</guid>
<pubDate>Wed, 15 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Peder L Myhre</dc:creator>
<dc:date>2023-11-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Omega-3 Fatty Acids and Atrial Fibrillation: The Difference Between Dietary Consumption and Supplementation</dc:title>
<dc:identifier>pmid:37968026</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.08.057</dc:identifier>
</item>
<item>
<title>Omega-3 Fatty Acids and Atrial Fibrillation Risk: A Controversy Resolved?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37968025/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 21;82(21):e203. doi: 10.1016/j.jacc.2023.08.058.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37968025/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37968025</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.08.058>10.1016/j.jacc.2023.08.058</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37968025</guid>
<pubDate>Wed, 15 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Hao Chen</dc:creator>
<dc:creator>Yunan Xu</dc:creator>
<dc:date>2023-11-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Omega-3 Fatty Acids and Atrial Fibrillation Risk: A Controversy Resolved?</dc:title>
<dc:identifier>pmid:37968025</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.08.058</dc:identifier>
</item>
<item>
<title>Omega 3, Atrial Fibrillation, and Cardiovascular Outcomes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37968024/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 21;82(21):e201-e202. doi: 10.1016/j.jacc.2023.08.059.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37968024/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37968024</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.08.059>10.1016/j.jacc.2023.08.059</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37968024</guid>
<pubDate>Wed, 15 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Evan L O'Keefe</dc:creator>
<dc:creator>Carl J Lavie</dc:creator>
<dc:creator>Andrew Elagizi</dc:creator>
<dc:creator>Richard V Milani</dc:creator>
<dc:creator>Jari A Laukkanen</dc:creator>
<dc:date>2023-11-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Omega 3, Atrial Fibrillation, and Cardiovascular Outcomes</dc:title>
<dc:identifier>pmid:37968024</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.08.059</dc:identifier>
</item>
<item>
<title>RESPONSE: Psychological Safety for Cardiology Trainees</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37968023/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 21;82(21):2066-2067. doi: 10.1016/j.jacc.2023.02.056. Epub 2023 Oct 26.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37968023/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37968023</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.02.056>10.1016/j.jacc.2023.02.056</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37968023</guid>
<pubDate>Wed, 15 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Margo Vassar</dc:creator>
<dc:creator>Sandra J Lewis</dc:creator>
<dc:date>2023-11-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>RESPONSE: Psychological Safety for Cardiology Trainees</dc:title>
<dc:identifier>pmid:37968023</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.02.056</dc:identifier>
</item>
<item>
<title>Psychological Safety in Cardiovascular Fellowship Training</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37968022/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 21;82(21):2063-2067. doi: 10.1016/j.jacc.2023.02.055. Epub 2023 Oct 31.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37968022/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37968022</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.02.055>10.1016/j.jacc.2023.02.055</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37968022</guid>
<pubDate>Wed, 15 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Vivek T Kulkarni</dc:creator>
<dc:date>2023-11-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Psychological Safety in Cardiovascular Fellowship Training</dc:title>
<dc:identifier>pmid:37968022</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.02.055</dc:identifier>
</item>
<item>
<title>Challenges and Controversies in Peer Review: JACC Review Topic of the Week</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37968021/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>The process of peer review has been the gold standard for evaluating medical science, but significant pressures from the recent COVID-19 pandemic, new methods of communication, larger amounts of research, and an evolving publication landscape have placed significant pressures on this system. A task force convened by the American College of Cardiology identified the 5 most significant controversies associated with the current peer-review process: the effect of preprints, reviewer blinding,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 21;82(21):2054-2062. doi: 10.1016/j.jacc.2023.08.056.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The process of peer review has been the gold standard for evaluating medical science, but significant pressures from the recent COVID-19 pandemic, new methods of communication, larger amounts of research, and an evolving publication landscape have placed significant pressures on this system. A task force convened by the American College of Cardiology identified the 5 most significant controversies associated with the current peer-review process: the effect of preprints, reviewer blinding, reviewer selection, reviewer incentivization, and publication of peer reviewer comments. Although specific solutions to these issues will vary, regardless of how scientific communication evolves, peer review must remain an essential process for ensuring scientific integrity, timely dissemination of information, and better patient care. In medicine, the peer-review process is crucial because harm can occur if poor-quality data or incorrect conclusions are published. With the dramatic increase in scientific publications and new methods of communication, high-quality peer review is more important now than ever.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37968021/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37968021</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.08.056>10.1016/j.jacc.2023.08.056</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37968021</guid>
<pubDate>Wed, 15 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Fred M Kusumoto</dc:creator>
<dc:creator>John A Bittl</dc:creator>
<dc:creator>Mark A Creager</dc:creator>
<dc:creator>Harold L Dauerman</dc:creator>
<dc:creator>Anuradha Lala</dc:creator>
<dc:creator>Mary M McDermott</dc:creator>
<dc:creator>Justine Varieur Turco</dc:creator>
<dc:creator>Viviany R Taqueti</dc:creator>
<dc:creator>Valentin Fuster</dc:creator>
<dc:creator>Peer Review Task Force of the Scientific Publications Committee</dc:creator>
<dc:date>2023-11-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Challenges and Controversies in Peer Review: JACC Review Topic of the Week</dc:title>
<dc:identifier>pmid:37968021</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.08.056</dc:identifier>
</item>
<item>
<title>Delineating the Benefits of an Invasive Strategy in Octogenarians With Non-ST-Segment Elevation Acute Coronary Syndromes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37968020/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 21;82(21):2031-2033. doi: 10.1016/j.jacc.2023.09.810.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37968020/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37968020</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.09.810>10.1016/j.jacc.2023.09.810</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37968020</guid>
<pubDate>Wed, 15 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>José A Barrabés</dc:creator>
<dc:creator>Eduard Ródenas-Alesina</dc:creator>
<dc:creator>Laia Milà</dc:creator>
<dc:date>2023-11-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Delineating the Benefits of an Invasive Strategy in Octogenarians With Non-ST-Segment Elevation Acute Coronary Syndromes</dc:title>
<dc:identifier>pmid:37968020</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.09.810</dc:identifier>
</item>
<item>
<title>Long-Term Outcomes of Invasive vs Conservative Strategies for Older Patients With Non-ST-Segment Elevation Acute Coronary Syndromes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37968019/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: In patients aged ≥80 years with NSTE-ACS, the invasive strategy was superior to the conservative strategy in the reduction of composite events and demonstrated a significant gain in event-free survival. (The After Eighty Study: a randomized controlled trial; NCT01255540).</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 21;82(21):2021-2030. doi: 10.1016/j.jacc.2023.09.809.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is a frequent cause of hospital admission in older people, but clinical trials targeting this population are scarce.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The After Eighty Study assessed the effect of an invasive vs a conservative treatment strategy in a very old population with NSTE-ACS.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Between 2010 and 2014, the investigators randomized 457 patients with NSTE-ACS aged ≥80 years (mean age 85 years) to an invasive strategy involving early coronary angiography with immediate evaluation for revascularization and optimal medical therapy or to a conservative strategy (ie, optimal medical therapy). The primary endpoint was a composite of myocardial infarction, need for urgent revascularization, stroke, and death. The long-term outcomes are presented.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: After a median follow up of 5.3 years, the invasive strategy was superior to the conservative strategy in the reduction of the primary endpoint (incidence rate ratio: 0.76; 95% CI: 0.63-0.93; P = 0.0057). The invasive strategy demonstrated a significant gain in event-free survival of 276 days (95% CI: 151-400 days; P = 0.0001) at 5 years and 337 days (95% CI: 123-550 days; P = 0.0001) at 10 years. These results were consistent across subgroups of patients with respect to major cardiovascular prognostic factors.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In patients aged ≥80 years with NSTE-ACS, the invasive strategy was superior to the conservative strategy in the reduction of composite events and demonstrated a significant gain in event-free survival. (The After Eighty Study: a randomized controlled trial; NCT01255540).</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37968019/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37968019</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.09.809>10.1016/j.jacc.2023.09.809</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37968019</guid>
<pubDate>Wed, 15 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Erlend S Berg</dc:creator>
<dc:creator>Nicolai K Tegn</dc:creator>
<dc:creator>Michael Abdelnoor</dc:creator>
<dc:creator>Kjetil Røysland</dc:creator>
<dc:creator>Pål Christie Ryalen</dc:creator>
<dc:creator>Lars Aaberge</dc:creator>
<dc:creator>Christian Eek</dc:creator>
<dc:creator>Erik Øie</dc:creator>
<dc:creator>Vibeke Juliebø</dc:creator>
<dc:creator>Erik Gjertsen</dc:creator>
<dc:creator>Anette Hylen Ranhoff</dc:creator>
<dc:creator>Lars Gullestad</dc:creator>
<dc:creator>Njord Nordstrand</dc:creator>
<dc:creator>Bjørn Bendz</dc:creator>
<dc:creator>After Eighty Study Investigators</dc:creator>
<dc:date>2023-11-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Long-Term Outcomes of Invasive vs Conservative Strategies for Older Patients With Non-ST-Segment Elevation Acute Coronary Syndromes</dc:title>
<dc:identifier>pmid:37968019</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.09.809</dc:identifier>
</item>
<item>
<title>Sleep, Hypoxia, and Survival in Group 1 Pulmonary Arterial Hypertension: What to Do?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37968018/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231119031019&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 21;82(21):2006-2008. doi: 10.1016/j.jacc.2023.10.005.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37968018/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231119031019&v=2.17.9.post6+86293ac">37968018</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.10.005>10.1016/j.jacc.2023.10.005</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37968018</guid>
<pubDate>Wed, 15 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Shahrokh Javaheri</dc:creator>
<dc:creator>Virend K Somers</dc:creator>
<dc:date>2023-11-15</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Sleep, Hypoxia, and Survival in Group 1 Pulmonary Arterial Hypertension: What to Do?</dc:title>
<dc:identifier>pmid:37968018</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.10.005</dc:identifier>
</item>





























</channel>
</rss>